Last edition
News about "Dr Reddy "
USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
Dr Reddy | 19/06/2023 | By Sudeep Soparkar | 564
Dr Reddy's acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products India
Following the trademark rights acquisition, Dr Reddy’s will manufacture the Active Pharmaceutical Ingredient (API) and finished drug at its state-of-the-art facilities
Dr Reddy | 17/01/2023 | By Sudeep Soparkar | 354
Dr Reddy's Labs buys injectable product portfolio from Eton Pharma
Dr Reddy’s acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.
Dr Reddy | 27/06/2022 | By Sudeep Soparkar | 266
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy